YD Bio YDES
NASDAQ YDES
$6.12 +0.20 (+3.38%)
At close: Oct 19, 2026 · 4:00 PM EDT

YD Bio (YDES) Liabilities and Shareholders Equity (2024 - 2026)

Updated

YD Bio's Liabilities and Shareholders Equity was $10.06 million in the quarter ended Jun 30, 2026, up 72.2% from $5.84 million a year earlier.

Analysis

YD Bio (YDES) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Liabilities and Shareholders Equity at YD Bio came in at $13.78 million, up 100.7% from the prior year.

  • In earlier years, Liabilities and Shareholders Equity was $6.86 million in the year ended Dec 31, 2024.
  • Quarterly Liabilities and Shareholders Equity has moved between $5.84 million (the quarter ended Jun 30, 2025) and $13.78 million (the quarter ended Dec 31, 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 201.06 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 135.12 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 115.83 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 49.36 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn 201.13 Bn
10 YD Bio 417.66 Mn 405.39 Mn - 10.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.06 Mn
Dec 31, 2025 13.78 Mn
Jun 30, 2025 5.84 Mn
Dec 31, 2024 6.86 Mn
API Access

YD Bio Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=YDES&period=max&api_key=YOUR_API_KEY